Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Clofibrate - Inositol Nicotinate
2. Clofibrate, Inositol Nicotinate Drug Combination
3. Liporeduct
1. 57456-45-8
2. 2-(4-chlorophenoxy)-2-methylpropanoic Acid;[2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] Pyridine-3-carboxylate
3. Clofibrate - Inositol Hexanicotinate Mixture
4. Inositol Hexanicotinate - Clofibrate Mixture
5. Clofibrate Mixture With Inositol Hexanicotinate
6. Clofibrate - Inositol Nicotinate
7. Clofibrate, Inositol Nicotinate Drug Combination
8. Myo-inositol, Hexa-3-pyridinecarboxylate, Mixt. With 2-(4-chlorophenoxy)-2-methylpropanoic Acid
Molecular Weight | 1025.4 g/mol |
---|---|
Molecular Formula | C52H41ClN6O15 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 21 |
Exact Mass | 1024.2318423 g/mol |
Monoisotopic Mass | 1024.2318423 g/mol |
Topological Polar Surface Area | 282 Ų |
Heavy Atom Count | 74 |
Formal Charge | 0 |
Complexity | 1420 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?